Hepatitis A and B combination Vaccine for adults and children/adolescents 2025-2027 (2027-2028, 2028-2029)
Ministry of Social Affairs and Health · Uusimaa
Perustiedot
- Hankkija
- Ministry of Social Affairs and Health, Y-tunnus 0244685-8
- Toteutuspaikka
- Uusimaa (FI1B1)
- Hankintalaji
- Tavarahankinta
- Menettely
- Avoin menettely, EU-hankinta
- Ilmoituksen tyyppi
- Jälki-ilmoitus
- Sopimusten kokonaisarvo
- 798 288 € (alv 0 %)
- Pääasiallinen CPV
- 33651600 Rokotteet
- Lisäkoodit: 33600000, 33650000
- Sopimuskausi
- 24 kuukautta
- Julkaistu
- 18.9.2025
Hankinnan tulos
| Voittaja | Sopimusarvo | Tarjouksia | Päätös |
|---|---|---|---|
| GlaxoSmithKline Oy, Y-tunnus 0108378-4 | 798 228 € | ei ilmoitettu |
Voittajista näytetään nimi ja Y-tunnus. ”Ei ilmoitettu” tarkoittaa, ettei ilmoituksessa ole tätä tietoa erälle tai sopimukselle.
Ilmoituksen teksti
Alkuperäinen teksti Hilmasta, muuttamattomanaThe Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Hepatitis A and B combination Vaccine belonging to the National Vaccination Programme in Finland.
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The most economically advantageous Tender shall be a Tender with lowest reference price for the competition. The reference price will be calculated by adding the tendered prices for adult and children/adolescent doses together. The tenderer must offer a price for both adult and children´s vaccines.
The contract period is two years 2025 - 2027. The procurement contains two one-year contract period renewals (1+1) to extend the contract for the periods 2027-2028 and 2028-2029.
Estimated quantity for the contract period including contract period renewals is 12 000 doses for adults and 1000 doses for children/adolescents. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%.
Please note that all times given in the Call for Tender refer to local time in Finland.
Call for Tenders, annexes:
Annex 1 Contract
Annex 2 JYSE 2014 SUPPLIES (updated version of April 2022)
Annex 3 Delivery schedule
Annex 4 Subcontractors
Annex 5 Description of the Handi Service
Lisätiedot
The purpose of STM and the Customer is to procure Hepatitis A and B combination Vaccine required for the National Vaccination Programme in Finland. The tendered vaccines must be suitable for adults and children/adolescents according to Article´s Summary of Product Characteristics (SPC). The Customer should prefer syringes without fixed needles.
This procurement is not divided into lots. According to Communicable Diseases Act (1227/2016) the Finnish Institute for Health and Welfare has an obligation to supervise the implementation of the national immunization programme and other general vaccinations and monitor the implementation and impact of the vaccinations. Dividing the procurement into lots could cause a risk for medication deviation if products with different dosages (different amount of doses in vaccination course or different concentrations) would be in use for adult and pediatric population.
More information about National Vaccination Programme and vaccinations can be found on the website of the Finnish Institute for Health and Welfare:
https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/hepatiittirokotteet/hepatiitti-a-ja-b-rokote
The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority".
The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders.
If the Supplier has modified vaccine available/ releases a modified vaccine during the contract period, the Parties may agree to substitute the Article with the modified vaccine. In case of substitution, all terms and prices in the Contract shall apply without modification.
CONTRACT PERIOD
The Contract shall enter into a force once the competent signatories of the Contracting Parties have duly signed the Contract. The Contract shall expire when all contractual duties and obligations have been performed by both Parties.
However, the contract period shall be counted from the first day of the month on which the Supplier has handed over the first delivery lot of the Articles to a Customer’s pharmaceutical wholesaler.
The Contract period is two (2) years from the date defined previously above and the estimated quantity to be purchased for this period is 6000 doses (+/- 20%) for adults and 500 doses (+/- 20%) for children/adolescents.
After the contract period, the Customer reserves the right for the contract period renewals described in section "Description of renewals".
Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tenders.
Hankinnan vaiheet
-
Tarjouspyyntö julkaistiin, määräaika 25.4.2025 klo 12.00.
-
Jälki-ilmoitustämä ilmoitus
Voittaja: GlaxoSmithKline Oy.